Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
8
|
pubmed:dateCreated |
1984-3-6
|
pubmed:language |
fre
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Oct
|
pubmed:issn |
0398-9771
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
32
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
493-9
|
pubmed:dateRevised |
2006-11-15
|
pubmed:meshHeading |
pubmed-meshheading:6319536-Antibodies, Viral,
pubmed-meshheading:6319536-Diagnosis, Differential,
pubmed-meshheading:6319536-Herpesvirus 4, Human,
pubmed-meshheading:6319536-Humans,
pubmed-meshheading:6319536-Nasopharyngeal Neoplasms,
pubmed-meshheading:6319536-Prognosis,
pubmed-meshheading:6319536-Time Factors
|
pubmed:year |
1983
|
pubmed:articleTitle |
[Symptomatologic value of the assay of EBV antibodies in carcinoma of the nasopharynx].
|
pubmed:publicationType |
Journal Article,
English Abstract
|